| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 医药中间体(元) | 10,016,904.66 | 32,577,115.33 | 4,388,304.80 |
| 原料药(元) | 223,538,189.61 | 460,967,546.45 | 233,595,561.36 |
| 制剂(元) | 307,924,602.67 | 683,286,133.88 | 356,963,746.74 |
| 营业成本(元) | |||
| 医药中间体(元) | 14,706,719.26 | 30,426,767.84 | 4,032,042.08 |
| 原料药(元) | 204,274,655.80 | 387,524,179.55 | 192,617,603.79 |
| 制剂(元) | 124,558,219.19 | 246,978,311.01 | 109,918,662.45 |
| 毛利(元) | |||
| 医药中间体(元) | -4,689,814.60 | 2,150,347.49 | 356,262.72 |
| 原料药(元) | 19,263,533.81 | 73,443,366.90 | 40,977,957.57 |
| 制剂(元) | 183,366,383.48 | 436,307,822.87 | 247,045,084.29 |
| 毛利率(%) | |||
| 医药中间体(%) | -46.82 | 6.60 | 8.12 |
| 原料药(%) | 8.62 | 15.93 | 17.54 |
| 制剂(%) | 59.55 | 63.85 | 69.21 |
| 收入构成(%) | |||
| 医药中间体(%) | 1.85 | 2.77 | 0.74 |
| 原料药(%) | 41.28 | 39.17 | 39.26 |
| 制剂(%) | 56.87 | 58.06 | 60.00 |
| 毛利构成(%) | |||
| 医药中间体(%) | -2.37 | 0.42 | 0.12 |
| 原料药(%) | 9.73 | 14.35 | 14.21 |
| 制剂(%) | 92.64 | 85.23 | 85.67 |